Rectal neuroendocrine tumour G2 presenting as a polyp with hepatic metastases

被引：0
|
作者：
Helal, I. [1 ]
Khanchel, F. [1 ]
Ben Thayer, M. [1 ]
Hmidi, A. [1 ]
Ben Brahim, E. [1 ]
Jouini, R. [1 ]
Chadli-Debbiche, A. [1 ]
机构：
[1] Habib Thameurs Hosp, Tunis, Tunisia
来源：
VIRCHOWS ARCHIV | 2021年 / 479卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-06-02
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [31] Capecitabine Temozolomide Efficacity and Tolerability in Metastatic Neuroendocrine in G2 Neurendocrine Neoplasm
    Bengueddach, A.
    Kehili, H.
    Allaoui, M.
    Benaoum, A.
    Tidjane, A.
    Boudjene, N.
    Tabeti, B.
    Mina, K.
    Larbi, H.
    Yamouni, M.
    NEUROENDOCRINOLOGY, 2019, 108 : 141 - 141
  • [32] Subgroup Analysis of Patients with gastro-pancreatic neuroendocrine Tumors G2
    Hauck, L.
    Bitzer, M.
    Malek, N.
    Plentz, R.
    INTERNIST, 2015, 56 : 23 - 23
  • [33] Prognostic Relevance of Aberrant DNA Methylation in G1 and G2 Pancreatic Neuroendocrine Tumors
    Stefanoli, Michele
    La Rosa, Stefano
    Sahnane, Nora
    Romualdi, Chiara
    Pastorino, Roberta
    Marando, Alessandro
    Capella, Carlo
    Sessa, Fausto
    Furlan, Daniela
    NEUROENDOCRINOLOGY, 2014, 100 (01) : 26 - 34
  • [34] Investigation of the reclassification of G1/G2 pancreatic neuroendocrine neoplasms by WHO 2017 classification
    Yokose, T.
    Kitago, M.
    Shinoda, M.
    Yagi, H.
    Abe, Y.
    Oshima, G.
    Hori, S.
    Endo, Y.
    Hayashi, K.
    Kitagawa, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [35] Analysis of the Genetic Characteristics and Metastatic Pathways of G1 and G2 Colorectal Neuroendocrine Neoplasms
    Wang, Zhijie
    Chen, Qichen
    Zhao, Fuqiang
    Sun, Li
    Qiu, Yixian
    Cheng, Huanqing
    Qin, Jiayue
    Wang, Huina
    Shi, Susheng
    Cao, Shanbo
    Liu, Qian
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (02)
  • [36] Thyroid transcription factor-1-positive neuroendocrine tumour of the ampullary region with multiple hepatic metastases: A case report
    Andrei, R. -T.
    Socoliuc, C. -G.
    VIRCHOWS ARCHIV, 2015, 467 : S125 - S125
  • [37] A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report
    Inoue, Manabu
    Tsukamoto, Shunsuke
    Moritani, Konosuke
    Sekine, Hideki
    Saito, Yutaka
    Kanemitsu, Yukihide
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2022, 94
  • [38] Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1–G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases
    Emilio Bertani
    Nicola Fazio
    Davide Radice
    Claudio Zardini
    Chiara Grana
    Lisa Bodei
    Luigi Funicelli
    Carlo Ferrari
    Francesca Spada
    Stefano Partelli
    Massimo Falconi
    Annals of Surgical Oncology, 2016, 23 : 981 - 989
  • [39] Gene Expression Signature Predicts Postoperative Recurrence of G1/G2 Pancreatic Neuroendocrine Tumors
    Miki, M.
    Oono, T.
    Fujimori, N.
    Takaoka, T.
    Miyasaka, Y.
    Ohtsuka, T.
    Nakamura, M.
    Ito, T.
    Ogawa, Y.
    PANCREAS, 2019, 48 (10) : 1490 - 1490
  • [40] Long-term outcomes and prognostic factors for neuroendocrine G1 and G2 lung tumors
    Waelscher, Julia
    Weinreich, Gerhard
    Theegarten, Dirk
    Ting, Saskia
    Tannapfel, Andrea
    Stamatis, Georgios
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345